Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-04-30

Assessment and improvement of selected technologies to remove or inactivate TSE - causing agents ("prions")

Objective



TSE causing agents ("prions") are extremely difficult to remove or inactivat especially if the biological activity of the matrix (e.g. enzymes, antibodies, plasma or othel biologically derived therapeuticals) must be retained. Nevertheless, some processes havE developed and shown to inactivate prions with high efficacy (e.g. the HAEMOSAFE proce others show potential to remove prions (e.g. reversed phase chromatography, hydrophot interaction chromatography, solvent extraction), but there exist contradictory results in lite as to what dearee. This project will determine the potential of these processes in 2 stages: a) they will be optimised for a number of key biologicals to yield unchanged biologic active products in high yield and purity b) the prion removal or inactivation will be demonstrated in spiking experiments. Thf be both IN VIVO and IN VITRO tests done in parallel in order to evaluate the pc of the newly emerging in vitro tests (DELFIA, western blot).

Topic(s)

Data not available

Call for proposal

Data not available

Coordinator

HAEMOSAN Erzuegung Pharmazeutischer Grundstoffe GesmbH.
EU contribution
No data
Address
20,Kahngasse
8045 Graz
Austria

See on map

Total cost
No data

Participants (1)